Showing 3,621 - 3,640 results of 18,571 for search 'significant ((((((greater decrease) OR (a decrease))) OR (we decrease))) OR (mean decrease))', query time: 0.73s Refine Results
  1. 3621

    Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  2. 3622

    Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  3. 3623
  4. 3624
  5. 3625
  6. 3626
  7. 3627
  8. 3628
  9. 3629
  10. 3630
  11. 3631
  12. 3632
  13. 3633
  14. 3634

    Alp5a and Alp5b are not individually required for asexual blood stage propagation, but simultaneously, they are indispensable for parasite viability. by Aastha Varshney (22601181)

    Published 2025
    “…The data are presented as the mean ± SEM, with no significant differences (P = 0.9864; one-way ANOVA). …”
  15. 3635
  16. 3636
  17. 3637
  18. 3638

    Study data. by Jie Liu (15128)

    Published 2025
    “…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …”
  19. 3639

    Summary of clinical outcomes after 9 months. by Jie Liu (15128)

    Published 2025
    “…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …”
  20. 3640

    Approval by the research ethics committee. by Jie Liu (15128)

    Published 2025
    “…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …”